Drug intelligence / Profile preview

renshen guipi wan

Development stage
Unknown
Lead developer
Liaoning Jindan Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Renshen Guipi Wan is a traditional Chinese medicine (TCM) manufactured by Liaoning Jindan Pharmaceutical, based on a classic formula from the Chinese Pharmacopoeia. It is composed of several herbal ingredients, including Panax ginseng, Astragalus membranaceus, and Angelica sinensis, which work synergistically to tonify qi and blood while strengthening the heart and spleen. The medicine is primarily indicated for patients suffering from Heart and Spleen Deficiency, a TCM syndrome characterized by symptoms such as palpitations, insomnia, forgetfulness, physical fatigue, and poor appetite. It is also used to treat conditions like anemia and functional uterine bleeding associated with spleen qi deficiency. The product is approved and marketed in China as an over-the-counter (OTC) or prescription herbal remedy.

Brand names
Renshen Guipi Wan
Other names
Ren Shen Gui Pi WanGinseng Spleen-Restoring Pills
02

Targets

GABA-B (Gamma-aminobutyric acid receptor type B)

Beyond the preview

Go deeper on renshen guipi wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on renshen guipi wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call